CVS Health Corporation (LON:0HRS)
75.10
+0.50 (0.67%)
At close: Sep 12, 2025
CVS Health Revenue
CVS Health had revenue of $98.43B USD in the quarter ending June 30, 2025, with 8.35% growth. This brings the company's revenue in the last twelve months to $384.33B, up 6.21% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$384.33B
Revenue Growth
+6.21%
P/S Ratio
0.25
Revenue / Employee
$1.28M
Employees
300,000
Market Cap
70.18B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
CVS Health News
- 18 days ago - CVS Health to pay more than $12M to settle drug pricing allegations in Massachusetts - Seeking Alpha
- 20 days ago - CVS is up because it faced the pain that's now hitting the rest of managed care, says Jim Cramer - CNBC
- 20 days ago - Jim Cramer talks what is driving CVS higher this year - CNBC
- 20 days ago - Jim Cramer says CVS stock is a buy at these levels. Here's why - CNBC
- 25 days ago - Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug - Investor's Business Daily
- 25 days ago - Only 2 Weeks Away – Register Now! Florida C-suite executives invited to HMG Strategy's 5th Annual C-Level Technology Leadership Summit on September 4 - Benzinga
- 25 days ago - CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans - Benzinga
- 25 days ago - CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans - Benzinga